Zoledronic acid (Reclast, Zometa) belongs to a class of medications called bisphosphonates that are prescribed for bone health. These medications are often given to breast cancer patients because they have a 68% higher risk of osteoporosis compared to women without cancer.
While these medications are beneficial for Show Full Answer
Zoledronic acid (Reclast, Zometa) belongs to a class of medications called bisphosphonates that are prescribed for bone health. These medications are often given to breast cancer patients because they have a 68% higher risk of osteoporosis compared to women without cancer.
While these medications are beneficial for preventing osteoporosis and managing bone metastases pain, there are some potential side effects to be aware of. A rare but serious side effect is osteonecrosis of the jaw (ONJ), which occurs in about 2% of cancer patients taking bone drugs. Signs of ONJ include:
• Jaw pain
• Infection
• Loose teeth
• Exposed jawbone through the gums
It's recommended to see a dentist about 4 weeks before starting treatment, as dental professionals should be considered part of your cancer care team.
October 7, 2025
Join
Your Privacy Choices
